Dr Reddy's Laboratories Ltd banner

Dr Reddy's Laboratories Ltd
SWB:RDDA

Watchlist Manager
Dr Reddy's Laboratories Ltd Logo
Dr Reddy's Laboratories Ltd
SWB:RDDA
Watchlist
Price: 12.4 EUR 2.48%
Market Cap: €2.1B

Relative Value

The Relative Value of one RDDA stock under the Base Case scenario is hidden EUR. Compared to the current market price of 12.4 EUR, Dr Reddy's Laboratories Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RDDA Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

RDDA Competitors Multiples
Dr Reddy's Laboratories Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Dr Reddy's Laboratories Ltd
SWB:RDDA
1.1T EUR 3.1 19.4 12.4 16.1
US
Eli Lilly and Co
NYSE:LLY
993.5B USD 15.2 48.1 32.4 34.5
US
Johnson & Johnson
NYSE:JNJ
590.8B USD 6.3 22 15.3 18.8
CH
Roche Holding AG
SIX:ROG
298B CHF 4.9 31.7 13.3 15.6
UK
AstraZeneca PLC
LSE:AZN
239.4B GBP 5.6 32 17.6 24.8
CH
Novartis AG
SIX:NOVN
246.7B CHF 5.6 22.7 14 17.9
US
Merck & Co Inc
NYSE:MRK
307.1B USD 4.7 16.8 10.5 12.3
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.5 10.6 7.9 9.2
US
Pfizer Inc
NYSE:PFE
153.9B USD 2.5 19.8 7.4 9.9
US
Bristol-Myers Squibb Co
NYSE:BMY
123.1B USD 2.6 17.5 7.3 9
P/E Multiple
Earnings Growth PEG
IN
Dr Reddy's Laboratories Ltd
SWB:RDDA
Average P/E: 24.1
19.4
-1%
N/A
US
Eli Lilly and Co
NYSE:LLY
48.1
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
22
7%
3.1
CH
Roche Holding AG
SIX:ROG
31.7
29%
1.1
UK
AstraZeneca PLC
LSE:AZN
32
26%
1.2
CH
Novartis AG
SIX:NOVN
22.7
15%
1.5
US
Merck & Co Inc
NYSE:MRK
16.8
14%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.6
7%
1.5
US
Pfizer Inc
NYSE:PFE
19.8
26%
0.8
US
Bristol-Myers Squibb Co
NYSE:BMY
17.5
17%
1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
Dr Reddy's Laboratories Ltd
SWB:RDDA
Average EV/EBITDA: 42.8
12.4
0%
N/A
US
Eli Lilly and Co
NYSE:LLY
32.4
18%
1.8
US
Johnson & Johnson
NYSE:JNJ
15.3
2%
7.6
CH
Roche Holding AG
SIX:ROG
13.3
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
17.6
11%
1.6
CH
Novartis AG
SIX:NOVN
14
9%
1.6
US
Merck & Co Inc
NYSE:MRK
10.5
7%
1.5
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
7.9
7%
1.1
US
Pfizer Inc
NYSE:PFE
7.4
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.3
-12%
N/A